Monterrey

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• COPD1 trial
• Fabry disease1 trial
• Lupus (SLE)1 trial
• Multiple myeloma1 trial
• Sjögren's disease1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting3 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Sanofi5 trials

Running trials

• Recruiting

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  NCT07190209· Phase 3· Sanofi· Source

• Active, not recruiting

  A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease

  NCT05206773· Phase 3· Sanofi· Source

• Active, not recruiting

  Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

  NCT05039840· Phase 2· Sanofi· Source

• Active, not recruiting

  A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

  NCT03319667· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Completed

  Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)

  NCT04572841· Phase 2· Sanofi· Source